Unlock instant, AI-driven research and patent intelligence for your innovation.

Granular body contg. polydroxy alkoxide acid ester

A technology of polyhydroxyalkanoate and granules, which is applied in the field of slow-release microcapsules, hemoglobin, cosmetic ingredients or fertilizer ingredients, gas, and phase fields, and can solve the problem of not being able to fully satisfy and it is difficult to obtain a uniform solution containing a large number of bubbles microparticles etc.

Inactive Publication Date: 2003-07-23
CANON KK
View PDF22 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0051] As mentioned above, in the microcapsules obtained by the previous method, because there is no hollow structure inside the microparticles, it is difficult to obtain uniform microparticles containing a large number of air bubbles. A large amount of drug must be administered, especially in myocardial imaging, and there is still a big problem that there is no effective imaging agent that can fully satisfy the required high imaging effect (contrast effect)
Administration of such microballoons in large quantities may place an excessive burden on the living body depending on the situation, and there is still a problem of further improvement in terms of safety.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Granular body contg. polydroxy alkoxide acid ester
  • Granular body contg. polydroxy alkoxide acid ester

Examples

Experimental program
Comparison scheme
Effect test

reference example 1

[0543] (Reference Example 1) Production of Transformants with pHB Synthetase Production Ability

[0544] The inventors have previously applied for a method for producing a transformant produced by the TB64 strain and capable of producing pHB synthetase, but specific examples thereof are listed here. The TB64 strain was cultured overnight at 30°C in 100ml of LB medium (1% peptone, 0.5% yeast extract, 0.5% sodium chloride, pH7.4), and then separated and recovered by the method of Ma-Ma- et al. Chromosomal DNA. The resulting chromosomal DNA was partially decomposed with restriction enzyme Sau3Al. For the preparation of the vector, pUC18 was used, cut with the restriction enzyme BamH1, dephosphorylated (Molecular Cloning, Vol. 1, p. 572, 1989, published by Cold Spring Harbor Laboratory), and DNA Ligation Kit Ver.11 (Takara Shuzo) was used to connect with the chromosome The Sou3Al part of the DNA breaks down the fragment junctions. Next, Escherichia coli (Escheichia Coli) HB101 ...

reference example 2

[0549] (Reference Example 2) Preparation of Transformants with GST Fusion pHB Synthetase Production Ability

[0550] Inoculate the PTB 64-pHB strain into 200ml of LB medium, culture it with shaking at 125 times / min at 37°C for 12 hours, recover the cells obtained in this way by centrifugation, and recover plasmid DNA by conventional methods.

[0551] For PTB 64-pHB, an oligonucleotide (SEQ ID NO: 1) for an upstream side primer and an oligonucleotide (SEQ ID NO: 2) for a downstream side primer were designed and synthesized (Amersham Pharmacia Biotech). The oligonucleotide was used as a primer, and PTB64-pHB was used as a template to carry out PCR, and the pHB synthetase gene with a Bam H1 restriction site upstream and a Xhol restriction site downstream was amplified to full length (LA, PCR kit; Baojiu Co., Ltd.) .

[0552] The refined PCR amplified product was digested with Bam H1 and Xhol, inserted into a site corresponding to the plasmid PGEX-6P-1 (manufactured by Amersham P...

reference example 3

[0553] (Reference Example 3) Preparation of pHB Synthetase

[0554] In 100 ml of 2XYT medium (ptone 16 g / L, yeast extract 10 g / L, Nacl 5 g / L, pH 7.0) supplemented with ampicillin (100 μg / L), pre-culture the obtained discovery strain at 30°C overnight.

[0555] This was added to 10 liters of 2XYT medium (peptone 16 g / L, yeast extract 10 g / L, Nacl 5 g / L, pH 7.0) supplemented with ampicillin (100 μg / L), and cultured at 30°C for 3 hours , adding isopropyl-β-D-thiogalactopyranoside (IPTG) to a final concentration of 1 mM, and culturing at 30° C. for 3 hours.

[0556] At 4°C, the recovered culture solution was centrifuged at 78000m / S2 (=8000G) for 10 minutes, and after removing the supernatant, the bacterial cell particles were resuspended in 500ml of PBS solution at 4°C. Inject each 40ml of the bacterial liquid into a container pre-cooled to 4°C, pressurize to 216MPa (=2200kg / cm 2 ), discharge the bacterial liquid from the nozzle a small amount each time, and carry out the bacte...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention provides a particulate construct such as microcapsules containing a drug, and serving a slow releasing preparation not associated with a practically unacceptable initial burst release but showing a practically acceptable zero-order release for a certain period and a producing method for such particulate construct, and a slow releasing preparation of a high drug content capable of stably incorporating the drug in the particulate construct such as microcapsules, and a producing method for such preparation. The invention also provides a particulate construct such as microcapsules utilizing a highly functional polymer compound and incorporating oil phase and / or water phase in solid phase, and a producing method therefor. Furthermore, the invention provides a particulate construct such as microcapsules having a hollow structure of a single polymer membrane as the outer shell and capable of containing many bubbles in the fine particles, and a producing method capable of preparing such construct with a high reproducibility. According to the invention, a particulate construct such as microcapsules is formed with polyhydroxyalkanoate of a specified structure and a drug for a desired purpose, an oil phase and / or a water phase, or a gaseous phase is included in such construct.

Description

technical field [0001] The present invention relates to granular bodies such as microcapsules, which are characterized in that they contain a solid phase formed by polyhydroxyalkanolate (hereinafter abbreviated as PHA), and are formed by at least one phase in a solid phase, a liquid phase, and a gas phase, and the above-mentioned Polyhydroxyalkanoate contains at least 3-hydroxyalkanoic acid as a monomer unit, and is characterized in that it is formed by coating at least one of the solid phase, liquid phase, and gas phase in which the PHA is included. Granular bodies such as microcapsules. In addition, the present invention relates to a method for producing granular bodies such as microcapsules, which is characterized in that it is a W / O type emulsion formed of a water phase and an oil phase containing at least PHA, or a W / O type emulsion is further emulsified in the water phase. W / O / W type emulsion, make PHA contain at least one phase of solid phase, liquid phase, and gas pha...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/16A61K8/11A61K8/35A61K9/50A61K47/48A61K49/22A61Q17/04B01J13/04B01J13/06B01J13/14
CPCB01J13/04A61K9/5031B01J13/14A61K47/48869A61K8/35A61K49/223A61Q17/04B01J13/06A61K2800/412A61K8/11A61K47/6925Y02A50/30A61K9/16
Inventor 矢野哲哉野本毅古崎真也本间务
Owner CANON KK